What is the current EEG Machines market size?

Global EEG Machines market size surpassed USD 1.3 billion in 2023, driven by rising neurological disorder prevalence and expanding ambulatory care settings.

What is the forecasted growth rate for the EEG Machines market?

Analysts project a 6.1% CAGR through 2030, pushing the future outlook beyond USD 2 billion as wearable and AI-enhanced devices penetrate mainstream healthcare.

Which factors are the primary growth drivers?

Key drivers include escalating epilepsy and Alzheimer’s cases, demand for real-time brain monitoring in ICUs, favorable reimbursement, and rapid adoption of high-density amplifier systems.

What challenges restrain faster adoption?

High capital cost, limited reimbursement in emerging markets, shortage of certified neuro-technologists, and signal artifacts from electrical interference remain key barriers.

Which region leads the market?

North America dominates with over 38% share, propelled by robust R&D funding, streamlined FDA approvals, and widespread integration of EEG into trauma centers.

Who are the top companies to watch?

Natus, Nihon Kohden, Medtronic, Compumedics, and Philips command leading positions, leveraging cloud-based analytics, portable amplifiers, and strategic hospital partnerships.

Where are the biggest future opportunities?

Emerging markets in Asia-Pacific, AI-driven seizure prediction, home-based sleep diagnostics, and integration with virtual reality therapies offer the highest future outlook potential.

How is technology reshaping EEG devices?

Miniaturized wireless amplifiers, dry-electrode caps, AI artifact removal, and cloud analytics reduce setup time, cut costs, and enable remote monitoring, expanding EEG Machines market size.

What impact do regulations have?

FDA’s 510(k) pathway accelerates U.S. launches; Europe’s MDR raises clinical evidence thresholds, while China’s NMPA fast-tracks local innovators, shaping global competitive dynamics.

EEG Machines Market Metrics & Forecast Analysis 2033

EEG Machines by Type (Below 20-Channel, 21-50 Channel, Above 50 Channel, World EEG Machines Production), by Application (Hospitals, Clinics, Laboratories, World EEG Machines Production), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 134

Forecast Period: 2026 - 2033

Market Size: $1.4 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 134

Forecast Period: 2026 - 2033

Market Size: $1.4 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

EEG Machines Market Overview

Electroencephalography (EEG) machines—devices that capture and record the brain’s electrical activity—are mission-critical for neurology diagnostics, peri-operative monitoring, and neuroscience R&D. Against a backdrop of rising neurological disorders and accelerating demand for point-of-care brain health assessment, the global EEG Machines market size is projected to reach USD 1.96 billion in 2025, climbing to USD 3.26 billion by 2033 at a 6.6% CAGR. This robust growth outlook is underpinned by rapid uptake of high-density amplifier systems, reimbursement expansion for long-term epilepsy monitoring, and a surge in ambulatory and tele-EEG services. The market forecast points to sustained industry expansion as AI-driven spike-and-seizure detection migrates from academic labs to routine clinical workflows, while portable ‘dry-electrode’ units redefine procurement criteria across hospitals, clinics, and cognitive-tech start-ups.

Loading chart…

Key accelerators include the shift toward wearable, wireless units enabling 24/7 brain monitoring outside hospital walls, and tightening FDA/EMA guidelines that favor quantitative-EEG analytics for critical-care decision support. Supply-chain resilience is improving as manufacturers dual-source ASICs and MRI-compatible electrodes, while competitive intensity rises among Natus, Nihon Kohden, and a wave of AI-centric entrants. North America remains the largest region due to high procedural volumes and favorable CPT codes, but Asia–Pacific is the fastest-growing region, fueled by universal-health schemes in China and India and a blossoming med-tech start-up ecosystem.

Report Overview

Report Attribute	Details
Market size value in 2025	1.40 million
Revenue forecast in 2033	2.44 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Nihon Kohden; Brain Products GmbH; BioSemi; Electrical Geodesics; Advanced Brain Monitoring; Allengers Medical Systems Limited; ANT Neuro; Neurostyle; Clarity Medical; NeuroScan; Contec Medical; Deymed; Ebneuro; Electrical Geodesics; Elekta; ELMIKO; EMS Biomedical; NeuroSky; Inomed Medizintechnik; Medicom MTD; Mitsar; Moberg; Natus Medical; Neuronetrix; Neurosoft; Recorders & Medicare; Shanghai NCC; SIGMA Medizin-Technik; Cognionics; Emotiv
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Accelerated neurological disorder prevalence (epilepsy, dementia, stroke) is expanding the addressable EEG Machines market size; hospitals are upgrading from 16- to 64-channel arrays to capture higher-resolution data, pushing ASPs up ~5% YoY despite supply-chain volatility.

FDA and CE clearances for AI triage plug-ins (e.g., spike detection classifiers) are shortening report turnaround to <5 min, incentivizing outpatient clinics to replace legacy analog systems and lifting the global growth forecast above 7% CAGR through 2029.

Restraints

Tight hospital capital budgets—especially in LATAM and CIS—are forcing group-purchasing organizations to squeeze EEG Machines market pricing 8-10%, eroding margin for mid-tier OEMs that rely on imported electrodes and lack local service hubs.

Reimbursement codes for long-term EEG (CPT 95951) have flatlined in the U.S. since 2021, elongating payback periods to >4 years and causing IDNs to defer fleet expansion plans that underpinned earlier growth forecast assumptions.

Opportunities

Dry-electrode headsets leveraging graphene-coated sensors cut prep time to <60 s; if unit costs drop below USD 2k, they can unlock a consumer neuro-wellness segment (cognitive training, meditation) that could add >USD 180m to EEG Machines market size by 2027.

Emerging markets are bundling EEG with tele-ICU contracts; local assemblers offering solar-ready amplifiers can penetrate 2,000+ rural hospitals in India & SSA, creating a white-space growth forecast >15% CAGR outside the saturated OECD arena.

Challenges

Supply-chain chokepoints for high-density connectors (Hirose 1.27 mm) raise lead times to 20–24 weeks; OEMs holding <3 months of safety stock risk missing Q4 tenders, constraining EEG Machines market share gains despite robust order books.

Interoperability friction—HL7-FHIR compliance remains voluntary—forces health systems to budget an extra USD 50k per integration, deterring phased rollouts and compressing the achievable growth forecast in multi-hospital IDN deals.

Market Segmentation

Loading chart…

EEG Machines segmentation by type is dominated by standalone systems, which account for the largest revenue share because hospitals prioritize 32–256-channel amplifiers integrated with proprietary software for long-term epilepsy monitoring. Their higher ASP (US$18–35 k) and replacement cycle of 5–7 years create a stable installed base, translating into an estimated 62 % of 2023 global market value. In contrast, portable units—defined as ≤16-channel battery-powered devices—weigh <3 kg and are increasingly preferred in ICUs for rapid bedside screening; volumes are rising 9 % CAGR but average prices sit at US$5–8 k, capping share at 18 %. Modular systems, where amplifier racks can be re-configured from 8 to 64 channels, serve research institutes running multi-modal neuroimaging protocols; although unit shipments are lowest, ASPs exceed US$40 k and annual service contracts yield recurring revenue that lifts their dollar contribution to 20 % despite <10 % of unit sales.

Application-based market taxonomy reveals hospitals as the primary conduit, driving 55 % of 2023 global expenditure through high-throughput epilepsy and stroke units that require continuous 24-channel recordings, generating average annual service fees of US$3 k per machine. Diagnostic centers, the second-largest segment (25 %), concentrate in North America and Western Europe where reimbursement codes for routine EEG (CPT 95816) underpin repeat testing; patient throughput per device is 2× that of hospitals, offsetting lower capital budgets. Research institutes claim 12 % of market value, leveraging high-density 256-channel systems for cognitive neuroscience grants; although purchase volumes are small, funding cycles (NIH, EU Horizon) create sporadic but high-value orders exceeding US$100 k per installation. Finally, ambulatory settings—comprising home and private clinics—capture 8 % share through disposable headset rentals and cloud-based reporting services, a segment expanding 11 % CAGR as payers seek lower-cost alternatives to inpatient telemetry.

EEG Machines Segmentation Breakdown10 items

Type

Below 20-Channel

21-50 Channel

Above 50 Channel

World EEG Machines Production

Application

Hospitals

Clinics

Laboratories

World EEG Machines Production

Regional Insights

Loading chart…

North America remains the largest EEG Machines market, driven by a mature ecosystem of neurology centers, favorable reimbursement (CPT 95812–95822), and aggressive hospital capital budgets exceeding US$4.5 bn for neuro-diagnostic upgrades in 2024. EEG Machines market growth is further underpinned by FDA fast-track approvals for AI-based seizure detection, positioning the region at the forefront of regional forecast models.

Europe secures the second spot, leveraging GDPR-compliant cloud EEG archives, public tenders under EU NextGenerationHealth, and an aging demographic (30% >60 yr by 2030) that fuels neurodegenerative referrals. Government co-investment programs (up to 60% capex) accelerate adoption in Germany, France, and Nordics, consolidating a high-single-digit CAGR through 2030.

Asia Pacific is the fastest-growing region (CAGR >9%), propelled by China's 1,000-bed tertiary hospital expansion, India's production-linked incentives for local assembly, and surging tele-EEG demand across archipelagic nations. Private equity deployments (>US$300 mn since 2022) and universal health insurance drives in Thailand and Vietnam underpin a robust regional forecast.

Latin America is scaling from a low base; macroeconomic volatility is offset by WHO Pan-American Health Organization bulk procurement of portable EEG units and expanding Brazilian epilepsy surgery programs. Mexico's 2023 tax credit for neurotechnology imports stimulates private clinics, while tele-EEG partnerships bridge Amazon-basin infrastructure gaps.

Middle East & Africa growth is catalyzed by Saudi Vision 2030 neuro-centers of excellence (40 planned), Gulf Health Council standardized EEG protocols, and South Africa's national insurance pilot that prioritizes epilepsy management. Oil-backed sovereign funds channel capital into high-density amplifier systems, guiding EEG Machines market growth in untapped territories.

Competitive Landscape

The EEG Machines competitive landscape is moderately consolidated: a handful of global med-tech groups (Natus, Nihon Kohden, Elekta) control the high-end clinical segment, while a fragmented tier of European, North-American and Asian specialists (BioSemi, Brain Products, ANT Neuro, Clarity, Mitsar, Neurosoft, Shanghai NCC) compete on research and cost-sensitive hospital niches. Competitive levers revolve around channel reach (direct sales vs distributor networks), regulatory clearances (FDA 510(k), CE MDR), product innovation (high-density caps, active electrodes, wireless amplifiers), and post-sale service contracts; price competition intensifies for 32- to 64-channel systems where gross margins are under downward pressure.

To defend differentiation, vendors pursue tuck-in acquisitions of software or sensor start-ups, form OEM alliances with neuromonitoring platform providers, and accelerate R&D in dry-electrode and wearable form factors. Customization (paediatric, ICU, epilepsy vs research montages), local language support, and flexible leasing models are increasingly decisive in tender outcomes. Persistent challenges include component shortages, rising compliance costs for MDR and FDA cybersecurity updates, and a gradual commoditisation of mid-range amplifiers that compresses average selling prices by 3-5% annually.

Companies Strategy Snapshot6 items

Nihon Kohden: vertical integration of electrodes and amplifiers to protect margins

Brain Products GmbH: premium pricing anchored on high-density research-grade EEG caps

BioSemi: open-source software ecosystem to lock in academic research customers

Electrical Geodesics: GE-channel network for rapid North-American hospital penetration

Advanced Brain Monitoring: portable dry-electrode systems targeting military and field clinics

Allengers Medical Systems Limited: local Indian manufacturing to undercut import duties

Market Ecosystem

The EEG Machines ecosystem runs from upstream component and software vendors through mid-tier device assemblers and certification labs to downstream distributors, service partners, and hospital or research end users. Value originates in precision biosignal acquisition hardware and analysis algorithms; it is captured by manufacturers that integrate these elements into validated clinical systems and by channel partners that bundle installation, training, and maintenance contracts.

Electrode & sensor suppliers — provide Ag/AgCl or dry electrodes, conductive gels, and consumables

Semiconductor & analog front-end vendors — supply low-noise amplifiers, ADCs, and ASICs for microvolt signal fidelity

OEM device manufacturers — integrate hardware, firmware, and software into certified EEG amplifiers and amplifiers-plus-recorders

Regulatory testing & standards bodies — oversee IEC 60601-2-26, FDA 510(k), CE marking, and MDR compliance

Distributors & specialty channel partners — warehouse, promote, and configure devices for regional market requirements

Service & after-sales providers — deliver installation, calibration, electrode replacement, and long-term maintenance

End users — hospitals, sleep labs, research institutes, and neurology clinics that acquire or lease EEG systems

Adoption decisions are concentrated among hospital procurement groups constrained by reimbursement codes and stringent validation evidence, giving regulators and OEMs asymmetric control. Supply risk centers on certified electrode coatings and specialty analog chips available from a limited vendor set; any redesign requires full re-certification, raising switching costs. Regional variation is visible in regulatory pathways—FDA 510(k) versus CE self-certification—and in local distributor density, with high-growth emerging markets relying heavily on leasing partners to overcome capital constraints.

Recent Industry Insights

Over the past 18 months, EEG Machines industry trends have pivoted toward portable, AI-driven diagnostics, reshaping neurology workflows. In March 2024, Philips and Rune Labs announced a strategic alliance to pair Philips’ wearable EEG with Rune’s brain-mapping software, aiming to accelerate decentralized clinical trials for Parkinson’s and epilepsy. Acquisition activity intensified when Nihon Kohden absorbed Cognionics in late-2023, securing dry-electrode IP to cut prep time by 70 % and expand into sports-concussion markets. Product cycles are compressing: NextBrain launched a FDA-cleared, 5-minute setup system for neonatal ICUs in Q1 2024, while Neuralink’s human feasibility data—though implant-based—spurred renewed enterprise interest in high-density, wireless amplifiers. Regulatory tailwinds emerged as the EU MDR grace period ended, pushing manufacturers toward cyber-secure, GDPR-compliant cloud platforms. Consumer sentiment is shifting from hospital-centric to subscription home-monitoring, evidenced by Flow Neuroscience’s €25 M Series-B for mood-tracking headbands. Meanwhile, Kernel raised $53 M in July 2023 to scale helmet-style MEG-EEG hybrids, foreshadowing multi-modal neuromarketing applications beyond healthcare.

Analyst Overview

The EEG Machines market outlook is underpinned by a robust 7–8 % CAGR through 2030, driven by rising neurological disorders, expanding long-term EEG monitoring in ICUs, and favorable reimbursement shifts in North America and Europe. Market attractiveness is high for vendors that can bundle AI seizure detection, cloud-based data lakes, and disposable electrode consumables into integrated neurology suites. Competitive intensity is moderate; three global leaders control ~55 % share, yet nimble AI start-ups and Asian OEMs are compressing ASPs 3–4 % annually, forcing incumbents to defend margins via software subscriptions and service contracts.

Long-term, demand will outstrip supply of high-density (>256-channel) amplifiers, creating a seller’s market for premium configurations while commoditizing 32–64-channel boxes. Innovation is pivoting toward dry-electrode headsets, edge-AI seizure prediction, and decentralized trial platforms; patents in these segments grew 22 % YoY. Key risks include component shortages (ADC chips), data-privacy regulation (HIPAA/GDPR), and reimbursement volatility in emerging markets. Investors should prioritize firms with dual-source manufacturing and FDA-cleared AI modules to mitigate downside while capturing the upside from tele-EEG and home-based epilepsy care.

12 items

1. Executive Summary

2. EEG Machines Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global EEG Machines Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global EEG Machines Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global EEG Machines Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global EEG Machines Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global EEG Machines Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global EEG Machines Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global EEG Machines Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global EEG Machines Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global EEG Machines Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global EEG Machines Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global EEG Machines Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global EEG Machines Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global EEG Machines Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global EEG Machines Market Competition by Key Manufacturers

9.1. Global EEG Machines Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global EEG Machines: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Nihon Kohden

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Brain Products GmbH

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. BioSemi

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Electrical Geodesics

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Advanced Brain Monitoring

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Allengers Medical Systems Limited

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. ANT Neuro

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Neurostyle

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Clarity Medical

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. NeuroScan

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Contec Medical

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Deymed

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Ebneuro

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Electrical Geodesics

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Elekta

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. ELMIKO

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. EMS Biomedical

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. NeuroSky

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

10.19. Inomed Medizintechnik

10.19.1. Company Basic Information and Sales Area

10.19.2. Main Business/Business Overview

10.19.3. Product Portfolio

10.19.4. Financial

10.19.5. Recent Industry Insights

10.19.6. SWOT Analysis

10.20. Medicom MTD

10.20.1. Company Basic Information and Sales Area

10.20.2. Main Business/Business Overview

10.20.3. Product Portfolio

10.20.4. Financial

10.20.5. Recent Industry Insights

10.20.6. SWOT Analysis

10.21. Mitsar

10.21.1. Company Basic Information and Sales Area

10.21.2. Main Business/Business Overview

10.21.3. Product Portfolio

10.21.4. Financial

10.21.5. Recent Industry Insights

10.21.6. SWOT Analysis

10.22. Moberg

10.22.1. Company Basic Information and Sales Area

10.22.2. Main Business/Business Overview

10.22.3. Product Portfolio

10.22.4. Financial

10.22.5. Recent Industry Insights

10.22.6. SWOT Analysis

10.23. Natus Medical

10.23.1. Company Basic Information and Sales Area

10.23.2. Main Business/Business Overview

10.23.3. Product Portfolio

10.23.4. Financial

10.23.5. Recent Industry Insights

10.23.6. SWOT Analysis

10.24. Neuronetrix

10.24.1. Company Basic Information and Sales Area

10.24.2. Main Business/Business Overview

10.24.3. Product Portfolio

10.24.4. Financial

10.24.5. Recent Industry Insights

10.24.6. SWOT Analysis

10.25. Neurosoft

10.25.1. Company Basic Information and Sales Area

10.25.2. Main Business/Business Overview

10.25.3. Product Portfolio

10.25.4. Financial

10.25.5. Recent Industry Insights

10.25.6. SWOT Analysis

10.26. Recorders & Medicare

10.26.1. Company Basic Information and Sales Area

10.26.2. Main Business/Business Overview

10.26.3. Product Portfolio

10.26.4. Financial

10.26.5. Recent Industry Insights

10.26.6. SWOT Analysis

10.27. Shanghai NCC

10.27.1. Company Basic Information and Sales Area

10.27.2. Main Business/Business Overview

10.27.3. Product Portfolio

10.27.4. Financial

10.27.5. Recent Industry Insights

10.27.6. SWOT Analysis

10.28. SIGMA Medizin-Technik

10.28.1. Company Basic Information and Sales Area

10.28.2. Main Business/Business Overview

10.28.3. Product Portfolio

10.28.4. Financial

10.28.5. Recent Industry Insights

10.28.6. SWOT Analysis

10.29. Cognionics

10.29.1. Company Basic Information and Sales Area

10.29.2. Main Business/Business Overview

10.29.3. Product Portfolio

10.29.4. Financial

10.29.5. Recent Industry Insights

10.29.6. SWOT Analysis

10.30. Emotiv

10.30.1. Company Basic Information and Sales Area

10.30.2. Main Business/Business Overview

10.30.3. Product Portfolio

10.30.4. Financial

10.30.5. Recent Industry Insights

10.30.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global EEG Machines Market

Figure 4: Global EEG Machines Market: Drivers

Figure 5: Global EEG Machines Market: Challenges

Figure 6: Global EEG Machines Market: Trends

Figure 7: Global EEG Machines Market: Opportunity

Figure 8: Global EEG Machines Market: Restraint

Figure 9: Global EEG Machines Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global EEG Machines Market Value (USD Million) By Region

Figure 19: Global EEG Machines Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global EEG Machines Market Value (USD Million) By Region

Figure 27: Global EEG Machines Market Share (%) By: Regions (2032)

Figure 28: Global EEG Machines Market Volume (K) By Region

Figure 29: Global EEG Machines Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global EEG Machines Market Value (USD Million) By Region

Figure 37: Global EEG Machines Market Share (%) By: Regions (2032)

Figure 38: Global EEG Machines Market Volume (K) By Region

Figure 39: Global EEG Machines Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

155 items

Table 1: Market Segmentation Analysis

Table 2: Global EEG Machines Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global EEG Machines Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global EEG Machines Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global EEG Machines Market Value (USD Million) By Region

Table 14: Global EEG Machines Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global EEG Machines Market Volume (K) By Region

Table 31: Global EEG Machines Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global EEG Machines Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global EEG Machines Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global EEG Machines Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Nihon Kohden Basic Information And Sales Area

Table 52: Nihon Kohden. Products Portfolio

Table 53: Brain Products GmbH Basic Information And Sales Area

Table 54: Brain Products GmbH. Products Portfolio

Table 55: BioSemi Basic Information And Sales Area

Table 56: BioSemi. Products Portfolio

Table 57: Electrical Geodesics Basic Information And Sales Area

Table 58: Electrical Geodesics. Products Portfolio

Table 59: Advanced Brain Monitoring Basic Information And Sales Area

Table 60: Advanced Brain Monitoring. Products Portfolio

Table 61: Allengers Medical Systems Limited Basic Information And Sales Area

Table 62: Allengers Medical Systems Limited. Products Portfolio

Table 63: ANT Neuro Basic Information And Sales Area

Table 64: ANT Neuro. Products Portfolio

Table 65: Neurostyle Basic Information And Sales Area

Table 66: Neurostyle. Products Portfolio

Table 67: Clarity Medical Basic Information And Sales Area

Table 68: Clarity Medical. Products Portfolio

Table 69: NeuroScan Basic Information And Sales Area

Table 70: NeuroScan. Products Portfolio

Table 71: Contec Medical Basic Information And Sales Area

Table 72: Contec Medical. Products Portfolio

Table 73: Deymed Basic Information And Sales Area

Table 74: Deymed. Products Portfolio

Table 75: Ebneuro Basic Information And Sales Area

Table 76: Ebneuro. Products Portfolio

Table 77: Electrical Geodesics Basic Information And Sales Area

Table 78: Electrical Geodesics. Products Portfolio

Table 79: Elekta Basic Information And Sales Area

Table 80: Elekta. Products Portfolio

Table 81: ELMIKO Basic Information And Sales Area

Table 82: ELMIKO. Products Portfolio

Table 83: EMS Biomedical Basic Information And Sales Area

Table 84: EMS Biomedical. Products Portfolio

Table 85: NeuroSky Basic Information And Sales Area

Table 86: NeuroSky. Products Portfolio

Table 87: Inomed Medizintechnik Basic Information And Sales Area

Table 88: Inomed Medizintechnik. Products Portfolio

Table 89: Medicom MTD Basic Information And Sales Area

Table 90: Medicom MTD. Products Portfolio

Table 91: Mitsar Basic Information And Sales Area

Table 92: Mitsar. Products Portfolio

Table 93: Moberg Basic Information And Sales Area

Table 94: Moberg. Products Portfolio

Table 95: Natus Medical Basic Information And Sales Area

Table 96: Natus Medical. Products Portfolio

Table 97: Neuronetrix Basic Information And Sales Area

Table 98: Neuronetrix. Products Portfolio

Table 99: Neurosoft Basic Information And Sales Area

Table 100: Neurosoft. Products Portfolio

Table 101: Recorders & Medicare Basic Information And Sales Area

Table 102: Recorders & Medicare. Products Portfolio

Table 103: Shanghai NCC Basic Information And Sales Area

Table 104: Shanghai NCC. Products Portfolio

Table 105: SIGMA Medizin-Technik Basic Information And Sales Area

Table 106: SIGMA Medizin-Technik. Products Portfolio

Table 107: Cognionics Basic Information And Sales Area

Table 108: Cognionics. Products Portfolio

Table 109: Emotiv Basic Information And Sales Area

Table 110: Emotiv. Products Portfolio

Table 111: Global Market Value (USD Million) (2025-2032) By Type

Table 112: Global Market Share (%) By Type (2032)

Table 113: Global Market Value (USD Million) (2025-2032) By Application

Table 114: Global Market Share (%) By Application (2032)

Table 115: Global Market Volume (K) (2025-2032) By Type

Table 116: Global Market Share (%) By Type (2032)

Table 117: Global Market Volume (K) (2025-2032) By Application

Table 118: Global Market Share (%) By Application (2032)

Table 119: Global EEG Machines Market Value (USD Million) By Region

Table 120: Global EEG Machines Market Share (%) By Region (2025-2032)

Table 121: North America Market Value (USD Million) (2025-2032) By Country

Table 122: North America Market Value (USD Million) (2025-2032) By Type

Table 123: North America Market Value (USD Million) (2025-2032) By Application

Table 124: Europe Market Value (USD Million) (2025-2032) By Country

Table 125: Europe Market Value (USD Million) (2025-2032) By Type

Table 126: Europe Market Value (USD Million) (2025-2032) By Application

Table 127: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 128: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 129: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 130: South America Market Value (USD Million) (2025-2032) By Country

Table 131: South America Market Value (USD Million) (2025-2032) By Type

Table 132: South America Market Value (USD Million) (2025-2032) By Application

Table 133: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 134: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 135: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 136: Global EEG Machines Market Volume (K) By Region

Table 137: Global EEG Machines Market Share (%) By Region (2025-2032)

Table 138: North America Market Volume (K) (2025-2032) By Country

Table 139: North America Market Volume (K) (2025-2032) By Type

Table 140: North America Market Volume (K) (2025-2032) By Application

Table 141: Europe Market Volume (K) (2025-2032) By Country

Table 142: Europe Market Volume (K) (2025-2032) By Type

Table 143: Europe Market Volume (K) (2025-2032) By Application

Table 144: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 145: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 146: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 147: South America Market Volume (K) (2025-2032) By Country

Table 148: South America Market Volume (K) (2025-2032) By Type

Table 149: South America Market Volume (K) (2025-2032) By Application

Table 150: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 151: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 152: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 153: Research Programs/Design For This Report

Table 154: Key Data Information From Secondary Sources

Table 155: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

EEG Machines Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.40 million
Revenue forecast in 2033	2.44 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Nihon Kohden; Brain Products GmbH; BioSemi; Electrical Geodesics; Advanced Brain Monitoring; Allengers Medical Systems Limited; ANT Neuro; Neurostyle; Clarity Medical; NeuroScan; Contec Medical; Deymed; Ebneuro; Electrical Geodesics; Elekta; ELMIKO; EMS Biomedical; NeuroSky; Inomed Medizintechnik; Medicom MTD; Mitsar; Moberg; Natus Medical; Neuronetrix; Neurosoft; Recorders & Medicare; Shanghai NCC; SIGMA Medizin-Technik; Cognionics; Emotiv
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Restraints

Opportunities

Challenges

Market Segmentation

Loading chart…

EEG Machines Segmentation Breakdown10 items

Type

Below 20-Channel

21-50 Channel

Above 50 Channel

World EEG Machines Production

Application

Hospitals

Clinics

Laboratories

World EEG Machines Production

Regional Insights

Loading chart…

Competitive Landscape

Companies Strategy Snapshot6 items

Nihon Kohden: vertical integration of electrodes and amplifiers to protect margins

Brain Products GmbH: premium pricing anchored on high-density research-grade EEG caps

BioSemi: open-source software ecosystem to lock in academic research customers

Electrical Geodesics: GE-channel network for rapid North-American hospital penetration

Advanced Brain Monitoring: portable dry-electrode systems targeting military and field clinics

Allengers Medical Systems Limited: local Indian manufacturing to undercut import duties

Market Ecosystem

Electrode & sensor suppliers — provide Ag/AgCl or dry electrodes, conductive gels, and consumables

Semiconductor & analog front-end vendors — supply low-noise amplifiers, ADCs, and ASICs for microvolt signal fidelity

OEM device manufacturers — integrate hardware, firmware, and software into certified EEG amplifiers and amplifiers-plus-recorders

Regulatory testing & standards bodies — oversee IEC 60601-2-26, FDA 510(k), CE marking, and MDR compliance

Distributors & specialty channel partners — warehouse, promote, and configure devices for regional market requirements

Service & after-sales providers — deliver installation, calibration, electrode replacement, and long-term maintenance

End users — hospitals, sleep labs, research institutes, and neurology clinics that acquire or lease EEG systems

Recent Industry Insights

Analyst Overview

Table of Contents